Merit Financial Group’s Agios Pharmaceuticals AGIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$207K Buy
6,232
+676
+12% +$23.6K ﹤0.01% 2186
2026
Q2
$206K Buy
+5,556
New +$169K ﹤0.01% 2101

Other funds holding AGIO

Merit Financial Group's AGIO Position: Q3 2026 in Review

Merit Financial Group increased its Agios Pharmaceuticals (AGIO) stake by 12% in Q3 2026, buying an estimated $23.6K and bringing the position to 6,232 shares worth $207K. The position accounts for ﹤0.01% of the portfolio, ranked #2186.

Merit Financial Group first reported a position in AGIO in Q2 2026 and has held it in 2 quarters since. 241 funds tracked by Wall St. Rank hold AGIO as of Q3 2026.

  • Merit Financial Group held 6,232 shares of Agios Pharmaceuticals worth $207K as of Q3 2026.
  • Merit Financial Group bought 676 Agios Pharmaceuticals shares in Q3 2026, an estimated $23.6K.
  • Agios Pharmaceuticals made up ﹤0.01% of Merit Financial Group's portfolio in Q3 2026, its #2186 holding.
  • Merit Financial Group first reported a position in Agios Pharmaceuticals in Q2 2026 and has held it in 2 quarters since.
  • 241 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q3 2026.

Based on Merit Financial Group's 13F filing for Q3 2026, filed 6 Nov 2026.